Gideon Goldstein

Gideon Goldstein's AcademicInfluence.com Rankings

Gideon Goldstein

Biology

#4470

World Rank

#6656

Historical Rank

Immunology

#191

World Rank

#200

Historical Rank

biology Degrees

Download Badge

Biology

Gideon Goldstein's Degrees

PhD Immunology Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Gideon Goldstein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gideon Goldstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. (1980) (1601)
Monoclonal antibodies defining distinctive human T cell surface antigens. (1979) (1394)
Separation of functional subsets of human T cells by a monoclonal antibody. (1979) (1001)
A monoclonal antibody reactive with human peripheral blood monocytes. (1980) (831)
A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. (1980) (671)
RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION (1981) (643)
Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. (1975) (629)
Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. (1983) (612)
Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression (1979) (582)
Further characterization of the human inducer T cell subset defined by monoclonal antibody. (1979) (573)
Reactivity of Langerhans cells with hybridoma antibody. (1981) (543)
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. (1981) (485)
Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. (1980) (448)
A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. (1979) (426)
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. (1981) (347)
A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. (1979) (324)
Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen (1987) (319)
The complete amino acid sequence of ubiquitin, an adenylate cyclase stimulating polypeptide probably universal in living cells. (1975) (304)
Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens (1982) (295)
Isolation of Bovine Thymin: a Polypeptide Hormone of the Thymus (1974) (281)
Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? (1981) (275)
Monoclonal antibodies OKT 11 and OKT 11A have pan‐T reactivity and block sheep erythrocyte “receptors” (1982) (266)
Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. (1982) (264)
Distribution of t lymphocyte subsets in the human bone marrow and thymus: an analysis with monoclonal antibodies. (1981) (262)
Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. (1980) (243)
Cutaneous T cell lymphoma: characterization by monoclonal antibodies. (1981) (237)
Human T lymphocytes of inducer and suppressor type occupy different microenvironments (1980) (232)
Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. (1976) (212)
Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies. (1983) (212)
Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population (1981) (209)
Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody (1982) (196)
Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36 (1978) (195)
Phenotypic heterogeneity and cellular origins of T cell malignancies. (1981) (188)
Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. (1986) (179)
Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. (1993) (177)
T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens. (1981) (168)
HIV–1 Tat protein as a potential AIDS vaccine (1996) (162)
The generation and regulation of lymphocyte populations: evidence from differentiative induction systems in vitro (1978) (158)
Age, thymic involution, and circulating thymic hormone activity. (1978) (155)
Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell binding (1984) (151)
Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset. (1982) (149)
Suppression of human T-cell mitogenesis and E-rosette formation by the monoclonal antibody OKT11A. (1981) (145)
PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION (1982) (142)
The amino acid sequence of thymopoietin II (1975) (138)
Delineation of human thymocyte differentiation pathways utilizing double-staining techniques with monoclonal antibodies. (1981) (136)
Thymopentin therapy reduces the clinical severity of atopic dermatitis. (1990) (133)
Functional subsets of human monocytes defined by monoclonal antibodies: a distinct subset of monocytes contains the cells capable of inducing the autologous mixed lymphocyte culture. (1983) (133)
EFFECTS OF CYCLOSPORIN A ON SUPPRESSOR AND INDUCER T LYMPHOCYTES IN PRIMARY BILIARY CIRRHOSIS (1980) (128)
Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man (1975) (128)
LYMPHOCYTE DIFFERENTIATION FROM PRECURSOR CELLS IN VITRO * (1975) (127)
Differentiation of T cells in nude mice (1975) (126)
Three distinct human thymopoietins are derived from alternatively spliced mRNAs. (1994) (124)
Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. (1974) (124)
T cell requirements for generation of helper factor(s) in man: analysis of the subsets involved. (1980) (121)
The Human Thymus (1970) (119)
THE ISOLATION OF THYMOPOIETIN (THYMIN) * (1975) (115)
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. (1986) (111)
Terminal deoxynucleotidyl transferase is found in prothymocytes (1976) (111)
OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3. (1986) (105)
Cellular origin and interactions involved in gamma-interferon production induced by OKt3 monoclonal antibody. (1982) (104)
Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens. (1980) (103)
Lymphocyte-differentiating hormone of bursa of fabricius. (1976) (103)
Generation and characterization of monoclonal antibodies reactive with human B lymphocytes. (1983) (101)
Modulation of T leukaemic cell phenotype with phorbol ester (1982) (98)
Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation. (1987) (95)
The human immune response to the OKT3 monoclonal antibody is oligoclonal. (1986) (94)
Functional and Developmental Compartments of Human T Lymphocytes (1980) (92)
Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat lamin-associated polypeptide 2. (1995) (90)
Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide. (1987) (86)
Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes. (1978) (85)
Thymic hormones and lymphoklnes (1984) (84)
Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptides. (1981) (84)
Tripeptide structure of bursin, a selective B-cell-differentiating hormone of the bursa of fabricius. (1986) (82)
Experimental autoimmune thymitis. An animal model of human myasthenia gravis. (1966) (82)
Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. (1981) (80)
Nuclear magnetic resonance studies of the denaturation of ubiquitin. (1977) (78)
Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis. (1982) (78)
Unusual phenotypes of human inducer T cells as measured by OKT4 and related monoclonal antibodies. (1981) (78)
The T4 surface antigen is involved in the induction of helper function. (1984) (77)
Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T cell differentiation (1975) (76)
Human T cell surface antigens bearing a structural relationship to HLA antigens. (1981) (75)
Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. (1981) (74)
One-month prophylactic use of OKT3 in cadaver kidney transplant recipients. (1988) (74)
EFFECTS OF IN VIVO ADMINISTRATION OF MONOCLONAL ANTIBODIES SPECIFIC FOR HUMAN T CELL SUBPOPULATIONS ON THE IMMUNE SYSTEM IN A RHESUS MONKEY MODEL (1983) (73)
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. (1982) (70)
The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs. (1968) (70)
T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. (1982) (68)
Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens. (1983) (68)
Thymopoietin-like substance in human skin. (1983) (68)
Thymitis and myasthenia gravis. (1966) (65)
Activated human B cells display a functional IL 2 receptor. (1985) (65)
T-lymphocyte subsets in peripheral blood and lung lavage in idiopathic pulmonary fibrosis and sarcoidosis: analysis by monoclonal antibodies and flow cytometry. (1982) (63)
Short in vitro half-life of thymopoietin32--36 pentapeptide in human plasma. (2009) (62)
Inducer and Suppressor T‐Cells in Hepatitis B Virus‐induced Liver Disease (2007) (61)
The relationship between T lymphocyte subsets and Ia-like antigen positive nonlymphoid cells in early stages of cutaneous T cell lymphoma. (1982) (61)
Five epitopes of a differentiation antigen on human inducer T cells distinguished by monoclonal antibodies. (1983) (60)
Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33). (2000) (60)
Thymus-repopulating capacity of cells that can be induced to differentiate to T cells in vitro. (1975) (59)
Expression of the OKT monoclonal antibody defined antigenic determinants in malignancy. (1981) (57)
Functional analysis of human T cell subsets defined by monoclonal antibodies. III. Regulation of helper factor production by T cell subsets. (1981) (54)
OKT4 AND OKT4A ANTIBODY TREATMENT AS IMMUNOSUPPRESSION FOR KIDNEY TRANSPLANTATION IN RHESUS MONKEYS (1985) (54)
Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen. (1984) (52)
CIRCULATING THYMIC-HORMONE ACTIVITY IN CONGENITAL IMMUNODEFICIENCY (1977) (52)
TREATMENT OF ACUTE GRAFT‐VERSUS‐HOST DISEASE WITH MONOCLONAL ANTIBODY OKT3 (1984) (52)
Functional effects of thymopoietin32-36 (TP5) on cytotoxic lymphocyte precursor units (CLP-U). I. Enhancement of splenic CLP-U in vitro and in vivo after suboptimal antigenic stimulation. (1980) (51)
Susceptibility of cytotoxic T lymphocyte (CTL) clones to inhibition by anti-T3 and anti-T4 (but not anti-LFA-1) monoclonal antibodies varies with the "avidity" of CTL-target interaction. (1985) (51)
Thymopoietin to thymopentin: experimental studies (1985) (51)
Endocrine function of the thymus affecting neuromuscular transmission. (1969) (49)
FUNCTIONAL ANALYSIS OF HUMAN T CELL SUBSETS DEFINED BY MONOCLONAL ANTIBODIES (1981) (49)
Bioassay determinations of thymopoietin and thymic hormone levels in human plasma. (1977) (45)
Functional analysis of human T cell subsets defined by monoclonal antibodies. II. Collaborative T-T interactions in the generation of TNP-altered-self-reactive cytotoxic T lymphocytes. (1981) (45)
Characteristics of preleukemia cells induced in mice. (1978) (44)
Distribution of antigens defined by OKB monoclonal antibodies on benign and malignant lymphoid cells and on nonlymphoid tissues. (1984) (44)
THYMOPOIETIN AND MYASTHENIA GRAVIS: NEOSTIGMINE-RESPONSIVE NEUROMUSCULAR BLOCK PRODUCED IN MICE BY A SYNTHETIC PEPTIDE FRAGMENT OF THYMOPOIETIN (1975) (44)
Effect of thymopoietin pentapeptide (TP5) on autoimmunity. I. TP5 suppression of induced erythrocyte autoantibodies in C3H mice. (1980) (43)
Electrophysiological changes similar to those of myasthenia gravis in rats with experimental autoimmune thymitis. (1968) (42)
Two B cell epitopes of HIV-1 Tat protein have limited antigenic polymorphism in geographically diverse HIV-1 strains. (2001) (42)
Stability of human lymphocyte differentiation antigens when stored at room temperature. (1983) (41)
ANTIGENIC AND FUNCTIONAL EVIDENCE FOR THE IN VITRO INDUCTIVE ACTIVITY OF THYMOPOIETIN (THYMIN) ON THYMOCYTE PRECURSORS * (1975) (41)
T cell development in normal and thymopentin-treated nude mice (1982) (41)
Classification of human lymphocytes and monocytes with the OK series of monoclonal antibodies. (1983) (41)
Retraction Notice (2017) (41)
Myasthenia gravis, thymectomy and serum thymic hormone activity. (1979) (40)
THYMIN: A THYMIC POLYPEPTIDE CAUSING THE NEUROMUSCULAR BLOCK OF MYASTHENIA GRAVIS * (1971) (39)
Possible action of human placental aminopeptidase N in feto-placental unit. (1993) (39)
Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice. (1982) (39)
Physical-chemical properties of ubiquitin. (1980) (38)
Differentiation of thymocytes: evidence that induction of the surface phenotype requires transcription and translation. (1976) (38)
Mode of action of levamisole. (1978) (38)
Biologic functions of the OKT1 T cell surface antigen. I. The T1 molecule is involved in helper function. (1984) (37)
An electron-microscope study of the human thymus: normal appearances and findings in myasthenia gravis and systemic lupus erythematosus. (1968) (36)
THYMOPOIETIN PENTAPEPTIDE TREATMENT OF PRIMARY IMMUNODEFICIENCIES (1983) (35)
Radioimmunoassay for thymopoietin. (1976) (35)
Unusually restricted anti‐isotype human immune response to OKT3 monoclonal antibody (1984) (35)
Heterogeneity of stem cells in severe combined immunodeficiency. (1976) (34)
Thymopoietin-induced acquisition of responsiveness to T cell mitogens. (1975) (34)
Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis. (1982) (34)
Thymopoietin and bursopoietin: induction signals regulating early lymphocyte differentiation. (1977) (33)
Binding of thymopoietin to the acetylcholine receptor. (1986) (33)
Hematopoietic thymocyte precursors: IV. Enrichment of the precursors and evidence for heterogeneity (1978) (32)
Immune regulation by characterized polypeptides (1987) (32)
Cell membrane perturbation of resting T cells and thymocytes causes display of activation antigens (1983) (31)
IMMUNOGLOBULIN ISOANTIGENS (ALLOTYPES) IN THE MOUSE (1966) (30)
Reactivity of Monoclonal Antibodies with Human Myeloid Precursor Cells (1981) (30)
The thymus in systemic lupus erythematosus: a quantitative histopathological analysis and comparison with stress involution. (1967) (29)
Thymus hormones do not induce proliferative ability or cytolytic function in PNA+ cortical thymocytes. (1985) (29)
Comparative efficacy of various routes of administration of thymopentin (TP-5) with consideration of degradative mechanisms. (2009) (28)
Thymectomy in Systemic Lupus Erythematosus (1963) (28)
CLEAVAGE OF ESTERS USING CARBONATES AND BICARBONATES OF ALKALI METALS : SYNTHESIS OF THYMOPENTIN (1991) (28)
Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy. (1987) (28)
Abnormalities of regulatory T-cell subpopulations in patients with primary immunoglobulin deficiencies. (1982) (28)
Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens. (1987) (28)
THYMOPOIETIN-LIKE SUBSTANCE IN HUMAN SKIN (1982) (27)
Biologically active analogs of thymopentin with enhanced enzymatic stability (1986) (26)
Thymopoietin and thymopentin enhance the levels of ACTH, beta-endorphin and beta-lipotropin from rat pituitary cells in vitro. (1987) (26)
Isolation and complete amino acid sequence of human thymopoietin and splenin. (1987) (26)
Calcium-dependent effect of the thymic polypeptide thymopoietin on the desensitization of the nicotinic acetylcholine receptor. (1987) (26)
CHAPTER FOUR – SIZE OF THE HUMAN THYMUS (1969) (26)
Solution conformation of thymopoietin32-36: a proton nuclear magnetic resonance study. (1980) (26)
Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. (1981) (25)
Surface antigen changes occurring in short-term cultures of activated human T lymphocytes: analysis by flow cytometry. (1982) (25)
Immunoglobulin isoantigens (allotypes) in the mouse. II. Allotypic analysis of three gammaG2-myeloma proteins from (NZB x BALB/c)F1 hybrids and of normal gammaG2-globulins. (1966) (24)
Histological and serological features of experimental autoimmune thymitis in guinea-pigs. (1967) (24)
CONTRASTING ABNORMALITIES IN THE THYMUS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS: A QUANTITATIVE HISTOLOGICAL STUDY. (1965) (24)
OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients. (1987) (23)
ONE‐MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS (1988) (23)
The effect of thymopoietin32-36 and ubiquitin on spontaneous immunopathology of New Zealand mice. (1979) (23)
Pharmacokinetic study of orthoclone OKT3 serum levels during treatment of acute renal allograft rejection. (1988) (23)
Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis. (1978) (22)
OKB7, a monoclonal antibody that reacts at or near the C3d binding site of human CR2. (1985) (22)
Contrasting effects of thymopentin and splenopentin on the capacity of female mice to reject syngeneic male skin. (1984) (22)
Whole blood culture for measuring mitogen induced T cell proliferation provides superior correlations with disease state and T cell phenotype in asymptomatic HIV-infected subjects. (1995) (22)
Functional analysis of human T cell subsets defined by monoclonal antibodies. VI. Distinct and opposing immunoregulatory functions within the OKT8+ population. (1984) (21)
Effects of a nonapeptide FTS on lymphocyte differentiations in vitro (1977) (21)
Early stages of human marrow lymphocyte differentiation: induction in vitro by thymopoietin and ubiquitin. (1979) (21)
Induction of human granulocyte differentiation in vitro by ubiquitin and thymopoietin. (1977) (20)
T cell subset abnormalities in tissue lesions developing during autoimmune disorders, viral infection, and graft-vs.-host disease. (1982) (20)
Modification of cytokine production by piroxicam. (1994) (19)
IRI-514, a synthetic peptide analogue of thymopentin, reduces the behavioral response to social stress in rats (1996) (19)
Comparison of antimouse and antihorse antibody production during the treatment of allograft rejection with OKT3 or antithymocyte globulin. (1987) (19)
Thymus and muscle. (1967) (19)
Distinct epitopes on the T8 molecule are differentially involved in cytotoxic T cell function. (1984) (19)
Biologically active conformations of thymopentin. Studies with conformationally restricted analogs. (2009) (19)
Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies. (1981) (18)
Plasma cells in the human thymus. (1966) (18)
Immunoregulation by thymopoietin. (1980) (18)
Biochemical characterization of a differentiation antigen shared by human epidermal langerhans cells and cortical thymocytes. (1982) (18)
Immunologic monitoring with monoclonal antibodies to human T-cell subsets. (1981) (18)
Thymopoietin radioreceptor assay utilizing lectin-purified glycoprotein from a biologically responsive T cell line. (1984) (18)
Monoclonal antibody specificity: Orthoclone OKT3 T-cell blocker. (1987) (18)
The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies. (1983) (17)
Thymopoietin, a Thymic Polypeptide, Specifically Interacts at Neuronal Nicotinic α‐Bungarotoxin Receptors (1989) (17)
OKT3 monoclonal antibody reversal of acute renal allograft rejection unresponsive to conventional immunosuppressive treatments. (1986) (17)
HIV-1 Tat B-cell epitope vaccination was ineffectual in preventing viral rebound after ART cessation (2012) (17)
The ontogeny of B lymphocytes. III. Opposite signals transmitted to B lymphocyte precursor cells by inducing agents and hormones (1976) (16)
Plasma-cell tumor induction in (NZB) x BALB/c)F1 hybrid mice. (1966) (16)
A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting. (2010) (16)
Subpopulations of human T lymphocytes occupy different microenvironments. (1981) (16)
Structural requirements for the biological activity of thymopentin analogs. (1985) (16)
Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. (1984) (16)
T LYMPHOCYTES IN BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS (1982) (16)
Proton NMR investigation of Ln3+ complexes of thymopoietin 32-36. (1981) (16)
A novel lymphocyte differentiating factor in serum of patients with mycosis fungoides and Sezary syndrome. (1979) (15)
Myasthenia gravis: clinical, serological and histological studies in relation to thymectomy. (1968) (15)
In vitro differentiation of two surface markers for immature T cells by the synthetic pentapeptide, thymopoietin. (1981) (15)
Antigens in thymus and muscle effective in inducing experimental autoimmune thymitis and the release of thymin. (1969) (15)
Immunoregulation with levamisole (1979) (15)
Experimental myasthenia gravis. (1971) (15)
Response to azathioprine in ulcerative colitis (1966) (15)
Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. (1981) (15)
Cooperativity of thymopoietin 32–36 (the active site) and thymopoietin 38–45 in receptor binding (1984) (15)
Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain. (1991) (14)
Orthoclone OKT3 treatment of acute renal allograft rejection. (1987) (14)
Solution Conformation of Peptides through 1H Nuclear Magnetic Double Resonance Measurement of Amide Hydrogen Exchange Rates: Study of the Active Pentapeptide Fragment of Thymopoietin (1980) (13)
Creating a useful panel of anti-T cell monoclonal antibodies. (1981) (13)
The reversible and irreversible toxic effects of anti-Hela cell rabbit serum upon human cell lines in tissue culture. (1958) (13)
Thymopentin (TP-5) potency in vivo is enhanced by slow infusion. (2009) (13)
THE INFLUENCE OF OKT8F TREATMENT ON ALLOGRAFT SURVIVAL IN RHESUS MONKEYS (1986) (13)
Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells. (1980) (13)
Crystallization and preliminary x-ray investigation of ubiquitin, a non-histone chromosomal protein. (1979) (13)
Alterations in immunoregulatory cells in lung cancer and smoking. (1982) (13)
Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin (1987) (13)
Immunohistochemical localization of bursin in epithelial cells of the avian bursa of Fabricius. (1989) (12)
Use of Orthoclone monoclonal antibodies in the study of selected dermatologic conditions. (1981) (12)
Characterization of blood mononuclear cells reacting with K 562 cells after yellow fever vaccination. (1982) (12)
Thymic germinal centres in myasthenia gravis: a correlative study. (1967) (11)
The thymus: experimental physiology, and pathology in man. (1966) (11)
A CASE OF DERMATOMYOSITIS TREATED WITH 6‐MERCAPTOPURINE AND AZATHIOPRINE (1965) (11)
Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels. (1990) (10)
OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection. (1987) (10)
Immunohistochemical localization of thymopoietin with an antiserum to synthetic Cys-thymopoietin28-39. (1986) (10)
Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients. (1990) (10)
Thymopoietin interacts at the α-bungarotoxin site of and induces process formation in PC12 pheochromocytoma cells (1990) (10)
Immunoreactive thymopoietin in the mouse central nervous system (1986) (10)
The differentiation of cytotoxic and hemagglutinating antibodies in anti-HeLa cell rabbit sera. (1960) (10)
Identification of a thymopoietin like substance in epidermal cells from normal human skin (1982) (10)
OKT3 induces suppressor cells for mixed lymphocyte and PHA mitogenic responses in human peripheral lymphocytes. (1981) (10)
Serum thymic hormone activity with systemic lupus erythematosus. (1981) (10)
Detection by ELISA of shed cell-surface molecules in serum. (1983) (9)
Amino Acid Sequence of Thymopoietin Isolated from Skin (1988) (9)
Nuclear magnetic resonance analysis of Gd3+-induced perturbations in thymopoietin 32-36: a study of amide and aromatic proton resonances. (1982) (9)
Thymopentin: stability considerations and potency by various routes of administration (1985) (9)
Enhanced Thymic Lymphocyte Response to Phytohaemagglutinin in Experimental Autoimmune Thymitis (1969) (9)
Invivo Application of Monoclonal-Antibodies Specific for Human T-Cell Subsets Permits the Modification of Immune Responsiveness in Rhesus-Monkeys (1983) (9)
Lupoid hepatitis: computer analysis defining "hepatitis" and "cirrhosis" phases and relationships between hepatocellular damage and immune reactions in the liver. (1967) (9)
Proton nuclear magnetic resonance study of an active pentapeptide fragment of ubiquitin. (1981) (9)
Exploratory clinical studies of a synthetic HIV-1 Tat epitope vaccine in asymptomatic treatment-naïve and antiretroviral-controlled HIV-1 infected subjects plus healthy uninfected subjects (2012) (9)
Thymopoietin, a thymic polypeptide, regulates nicotinic alpha-bungarotoxin sites in chromaffin cells in culture. (1990) (8)
Combination autoradiography and membrane fluorescence in studying cell cycle transplantation antigen relationships. (1971) (8)
Thymopoietin and ubiquitin. (1985) (8)
Myasthenia gravis and the thymus. (1971) (8)
Bursin Localization in Mammalian Bone Marrow and Epithelial Cells of Intrahepatic Bile Ducts (1990) (8)
In vitro effects of thymopentin on the gamma-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritis. (1987) (8)
Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction. (1990) (7)
Thymopoietin, a potent antagonist at nicotinic receptors in C2 muscle cell cultures. (1991) (7)
Human antibody response to antilymphocytic preparations in renal transplant patients. (1987) (7)
Null cell identification and characterization with OKT16: an anti-p40 monoclonal antibody. (1985) (7)
Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments. (1987) (6)
Monoclonal antibodies to human T cell subsets: use for immunological monitoring and immunosuppression in renal transplantation. (1982) (6)
Immunoassay for bovine serum thymopoietin: discrimination from splenin by monoclonal antibodies. (1984) (6)
An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia. (1980) (6)
Immunoregulatory influence of thymic epithelium and thymopoietin on human B-lymphocyte differentiation. (1980) (6)
Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression (2000) (6)
Bovine probursin tetradecapeptide contains amino acid sequence from somatostatin, tuftsin and bursin. (1991) (6)
Selected human T cell lines respond to thymopoietin with intracellular cyclic GMP elevations. (1988) (5)
Thymopoietin: A Marker of the Human Nicotinic Acetylcholine Receptor (1988) (5)
Therapeutic use of monoclonal antibodies in kidney transplantation. (1985) (5)
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. (1995) (5)
STRUCTURE AND DEVELOPMENT OF THE HUMAN THYMUS (1969) (5)
CHAPTER SEVEN – THYMIC TUMOURS AND SYSTEMIC DISEASES ASSOCIATED WITH THYMOMA (1969) (5)
Monoclonal antibody for reversal of acute renal allograft rejection in pediatric patients. (1985) (5)
Infantile thymectomy: alterations in circulating T-cell subpopulations and in vitro effects of thymopoietin pentapeptide. (1979) (5)
Mast cells in the human thymus. (1966) (5)
Resting and activation antigens of T cells: studies with OKT10 and OKT20 monoclonal antibodies. (1983) (5)
Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases. (1975) (4)
Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice (2004) (4)
The Thymus, Thymosin and Anti‐Thymosin 1, 2 (1970) (4)
Use of monoclonal antibodies to identify thymopoietin in cultured human thymic epithelial cells. (1991) (4)
Chemical synthesis of a hexadecapeptide segment of ubiquitin that activates adenylate cyclase and induces lymphocytes to differentiate (1978) (4)
REGULATORY INFLUENCE OF THYMOPENTIN ON SPLENIC T CELL SETS OF THYMECTOMIZED AND AGED MICE1,2 (1985) (4)
The Human Thymic Microenvironment (2008) (4)
Monitoring immunosuppression following renal transplantation. (1983) (4)
Thymopoietin, a thymic polypeptide, prevents nicotinic agonist-induced morphological changes in neonatal muscle cells in culture (1992) (3)
Ia DETERMINANTS ON H U M A N T-CELL SUBSETS DEFINED BY MONOCLONAL ANTIBODY (2003) (3)
T-Lymphocyte Subsets in Smoking and Lung Cancer (2015) (3)
The human thymic environment. (1981) (3)
Thymopoietin, a polypeptide ligand for the α-bungarotoxin binding site in brain: An autoradiographic study (1992) (3)
Antibodies to thymopoietin following implantation of paper disks derivatized with synthetic Cys-thymopoietin. (1986) (3)
[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]. (1987) (3)
Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines (1990) (3)
Pillars article: Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979. 206: 347-349. (2013) (2)
The challenge of immunoregulation. (1981) (2)
Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction. (1990) (2)
Editorial: "Myasthenia gravis" or the autoimmunity, thymic disease, neuromuscular block poser. (1975) (2)
INDUCTION OF SURFACE RECEPTORS ON GRANULOCYTE, T, AND B CELL PRECURSORS IN HUMAN BONE MARROW BY THYMIC AND NON-THYMIC AGENTS (1976) (2)
Monoclonal antibodies for the treatment of acute rejection episodes in renal transplantation (1985) (2)
Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies. (1983) (2)
Notice of retraction. (1993) (2)
Pillars article: Separation of functional subsets of human T cells by a monoclonal antibody. Proc. Natl. Acad. Sci. 1979. 76: 4061-4065. (2013) (2)
Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. (1983) (2)
Spray-dried enteric solid dispersion as a novel oral delivery system for a pentapeptide analog of thymopentin (1992) (2)
Lead and cadmium inhibition of DNA biosynthesis (1974) (2)
Notice of retraction. (1993) (2)
monoclonal antibody Null cell identification and characterization with OKT16: an anti-p40 (2013) (1)
Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS). (1983) (1)
CHAPTER THREE – THE THYMUS AND EXPERIMENTAL PATHOLOGY (1969) (1)
Monoclonal antibodies in clinical medicine (1983) (1)
Lymphocyte differentiations induced by thymopoietin, bursopoietin and ubiquitin. (1978) (1)
Thymopoietin a thymic polypeptide inhibits function and nicotinic receptor binding at the neuromuscular junction (1990) (1)
Preparation of biologically active radioiodinated thymopentin (1991) (1)
CHAPTER SIX – THYMITIS AND MYASTHENIA GRAVIS (1969) (1)
Immune regulation by characterized polypeptides : proceedings of an Ortho-UCLA Symposium held in Steamboat Springs, Colorado, January 25-February 1, 1986 (1987) (1)
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts (1982) (1)
Accessibility of plasma membrane antigens (1977) (1)
IMMUNOREGULATION BY THYMOPOIETIN AND BURSOPOIETIN (ABSTRACT) (1979) (0)
LIMITED SURGICAL THYROID BIOPSY. (1963) (0)
CHAPTER NINE – CLINICAL INVESTIGATION OF THE THYMUS AND RELATED DISEASES (1969) (0)
The enzyme-resistant peptides immonumodulatoriske (1984) (0)
fungoides and Sezary syndrome A novel lymphocyte differentiating factor in serum of patients with mycosis (2013) (0)
Thymopoietin, a thymic hormone as cofactor of pathogenic antibodies in myasthenia gravis (1991) (0)
Monoclonal Antibodies to Lymphocyte Surface Molecules as Probes for Lymphocyte Functions (1988) (0)
Analogifremgangsmaade for the preparation of the tripeptides or pharmaceutically acceptable acid addition salts thereof (1980) (0)
I-cell hybridomas be aligned Foer framstaellning of a komplementbindande Monoklonale antikropp against maenskliga T-celler antikroppen samt therapeutic efficacy Science diagnostisk metoder at which there antikroppen anvaendes (1980) (0)
Unique features of human and monkey xenosensitization against anti-T cell murine monoclonals (1985) (0)
Peptides having T-cellsuppressoraktivitet. (1990) (0)
Mono clonal antibodies use in the diagnosis and therapy of human disease (1984) (0)
Correction: Binding of Thymopoietin to the Acetylcholine Receptor (1993) (0)
Thymopoietin, a thymic polypeptide, prevents nicotinic agonist-induced morphological changes in neonatal muscle cells in culture. (1993) (0)
Retraction (1993) (0)
Techniques for Characterization of Leucocyte Antigens and Utilization of Antibodies in Therapy (1984) (0)
A monoclonal antibody-producing hybrid cell line, antibodies and methods for its preparation, these antibody-containing therapeutic composition, and their diagnostic and therapeutic uses. (1980) (0)
Monoclonal antibody, its preparation, hybridoma cell line for use in the manufacture thereof, and methods of use thereof (1980) (0)
Peptides with T cell helper activity. (1989) (0)
Treatment of Active Chronic Graft Versus Host Disease of the Skin with Monoclonal Antibody OKT3.Pan (1985) (0)
mAbs to Human Lymphocyte Surface Antigens (2019) (0)
Peptides with T helper cell activity (1990) (0)
Notice of retraction. (2018) (0)
Isolation of a Polypeptide That Has LymF and Is Probably Represented Universally j (2016) (0)
Foerfarande Foer framstaellning of a Monoklonale antikropp against maenskliga T-Cellers antigener with a ny hybridcellinje. (1981) (0)
Neuronal nicotinic alpha-bungarotoxin receptors. (1990) (0)
A process for preparing a monoclonal antibody, hybridoma cell line for use in the method as well as the method for diagnosis and diagnostic composition of the produced monoclonal antibody (1980) (0)
Immunopharmacologic Applications of Monoclonal Antibodies to Human Lymphocytes (1983) (0)
TE671 cell and solubilized human muscle acetylcholine receptors: Similarities and differences in immunological properties (1989) (0)
Hybrid cell line and process for production thereof (1980) (0)
Biologicals and Immunologicals Peptide immunomodulators: progress and prospects (1994) (0)
Monoclonal antibodies and immobilized antibodies (1987) (0)
Analogifremgangsmaade for the preparation of peptides containing amino acid residues 2-7, desaminodipeptider or amides thereof having ubiquitin-like activity, or pharmaceutically acceptable acid addition salts thereof (1980) (0)
CHAPTER FIVE – THYMIC HYPOPLASIA AND IMMUNOLOGICAL DEFICIENCIES (1969) (0)
Assay for Dissociation of Functional CTL-Target Cell Conjugates (2003) (0)
Hybrid cell line and method of making and use thereof (1980) (0)
Hybridoma producing igg monoclonal antibody (1988) (0)
THE G E N E R A T I O N A N D REGULATION OF LYMPHOCYTE P O P U L A T I O N S Evidence from Differentiative Induction Systems in Vitro* (2003) (0)
Monoclonal antibody, its preparation, hybrodimacellelinie for use in the preparation thereof, method of use thereof as well as diagnostic composition comprising the antibody (1980) (0)
Hybrid cell line for producing monoclonal antibodies against a human monocyte antigen, antibodies and methods. (1981) (0)
Overview Biologicals and Immunologicals: Peptide immunomodulators: progress and prospects (1994) (0)
Process for T cell helper activity in the preparation of the peptides (1990) (0)
OKT3 induced natural cell-mediated cytotoxicity of lymph node cells in breast cancer (1982) (0)
DIFFERENTIATION OF T CELLS IN VITRO (1977) (0)
Monoclonal Antibodies as Pharmacological Agents (1986) (0)
CHAPTER EIGHT – THE HUMAN THYMUS IN EXTRA-THYMIC DISEASES (1969) (0)
1728 THE GENERATION AND REGULATION OF LYMPHOCYTE POPULATIONS cells from mice st imulated with Corynebacterium parvum (2003) (0)
CHAPTER TEN – TREATMENT OF THYMIC DISEASES AND RELATED SYSTEMIC DISEASES (1969) (0)
[In vivo induction of antigenic modulation in man by an anti-T cell monoclonal antibody (author's transl)]. (1982) (0)
A process for preparing a monoclonal antibody, hybridoma cell line for use in the method as well as the method for diagnosis using the monoclonal antibody produced (1980) (0)
Isolation and complete amino acid sequence of human thymopoietin and splenin. (1994) (0)
Cells by the sysnthetic pentapeptide, thymopoietin32-36. (1981) (0)
Diketopiperazine derivatives and process for their preparation (1981) (0)
T & b lymphocyte precursors in the mouse spleen. Abstr. (1980) (0)
CHAPTER TWO – FUNCTIONS OF THE THYMUS (1969) (0)
(thymic hormone/polypeptides/myasthenia gravis/neuromuscular transmission) (2017) (0)
Correction (1982) (0)
A process for the preparation of tymopentiinianalogien (1985) (0)
Monoclonal antibody and method for its manufacture (1980) (0)
United States Patent ( 19 ) Kung et al . 54 MONOCLONAL ANTIBODY TO HUMAN CYTOTOXC AND SUPPRESSORT CELLS AND METHODS OF PREPARING SAME 75 (2017) (0)
Monoclonal antibody to human helper T-cells, process for its preparation, it producing hybrid cell line, its diagnostic and therapeutic uses, and these antibody-containing diagnostic and therapeutic compositions. (1980) (0)
The enzyme-resistant immunomodulatory peptides thymopoietin- or spleninanaloge and their pharmaceutically acceptable acid or base addition salts as well as process for their preparation (1984) (0)
Thymopoietin Potently and Specifically Interacts with the Nicotinic α-Bungarotoxin Receptor in Neuronal Tissue (1991) (0)
Foerfarande Foer framstaellning of a Monoklonale antikropp against maensklig monocytantigen en ny means of a hybridcellinje. (1981) (0)
Polypeptides, methods for their manufacture and to compositions comprising drug (1978) (0)
Active thymopentin analogues. (1985) (0)
T cells and immunoregulation: a contemporary overview. (1982) (0)
Effect of thymopoietin on lymphocyte mediated cytotoxicity. Abstr. (1979) (0)
Hybrid cell line for producing monoclonal antibodies against a human antigen-prothymozyt (1980) (0)
Effects of thymopoietin and myasthenia gravis sera on α-Bgt binding sites in rat myotube cultures (1991) (0)
IMMUNOGLOBULIN ISOANTIGENS (ALLOTYPES) IN THE MOUSE II. ALLOTYPIC ANALYSIS 0~" TB.REE ")'GrMYELOMA PROTEINS YROM (NZB X BALB/c)F1 HYBRIDS AND OF NOP.MAI. (2013) (0)
Evidence for the functional involvement of T cell differentiation antigens inT (2003) (0)
Immunoregulatory mechanisms: dissection and diagnosis with monoclonal antibodies. (1983) (0)
changes similar tothose of myasthenia gravis inratswithexperimental autoimmune thymitis (1968) (0)
Binding of thymopoietin to acetyl-receptor of rat: Study on embryo muscle culture and motor enplate (1989) (0)
Peptides with T-cellesuppressoraktivitet (1990) (0)
Induction of T-Cell Differentiation In Vii Polypeptide Hormone of the Thymus (2016) (0)
Radioimmunoassay for thymopoietin. [/sup 125/I tracer technique] (1976) (0)
A process for preparing a monoclonal antibody as well as the method for diagnosis and hereby diagnostic composition comprising the antibody (1980) (0)
Analogifremgangsmaade for the preparation of pentapeptide derivatives or pharmaceutically acceptable salts thereof (1980) (0)
Foerfarande Foer framstaellning a complement of the I-bindande Monoklonale antikropp against maenniskans T-celler through anvaendning of a ny hybridcellinje. (1980) (0)
TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT 3 MONOCLONAL ANTIBODY 1 A (2017) (0)
Thymopoietin: A marker of the human nicotinic acetylcholine receptor (H.AChR) (1987) (0)
Correction (1983) (0)
Foerfarande Foer framstaellning of Monoklonale antikropp to the maensklig protymocytantigen by means deras hybridcellinje. (1980) (0)
The test kit foerfarande, at Vilket anvaends en ny Monoklonale antikropp specifik against maenniskans hjaelpare-t-celler. (1984) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gideon Goldstein?

Gideon Goldstein is affiliated with the following schools:

McGill University

Gideon Goldstein's Academic­Influence.com Rankings